BIM
ISEE

Bogle Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bogle Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-102,502
Closed -$353K – 445
2020
Q1 		$353K Buy
+102,502
New +$599K 0.04% 226
2019
Q4 		– Sell
-29,067
Closed -$33K – 337
2019
Q3 		$33K Hold
29,067
– – ﹤0.01% 262
2019
Q2 		$38K Sell
29,067
-2,691
-8% -$3.69K ﹤0.01% 268
2019
Q1 		$45K Sell
31,758
-5,100
-14% -$7.13K ﹤0.01% 270
2018
Q4 		$44K Sell
36,858
-7,834
-18% -$15.2K ﹤0.01% 318
2018
Q3 		$105K Sell
44,692
-20,210
-31% -$50.4K 0.01% 261
2018
Q2 		$177K Sell
64,902
-135,180
-68% -$373K 0.01% 265
2018
Q1 		$548K Sell
200,082
-195,361
-49% -$566K 0.04% 266
2017
Q4 		$1.23M Sell
395,443
-53,398
-12% -$150K 0.09% 204
2017
Q3 		$1.26M Sell
448,841
-261,443
-37% -$706K 0.09% 202
2017
Q2 		$1.82M Sell
710,284
-399,677
-36% -$1.09M 0.13% 154
2017
Q1 		$4.06M Sell
1,109,961
-169,490
-13% -$716K 0.28% 112
2016
Q4 		$6.18M Buy
+1,279,451
New +$38M 0.43% 85

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bogle Investment Management's ISEE Position: Q2 2020 in Review

Bogle Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2020, closing a stake of 102,502 shares — an estimated $353K sold.

Bogle Investment Management first reported a position in ISEE in Q4 2016 and held it in 13 quarters. The position peaked at $6.18M in Q4 2016. 119 funds tracked by Wall St. Rank hold ISEE as of Q2 2020.

  • Bogle Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 102,502 IVERIC bio, Inc. Common Stock shares in Q2 2020, an estimated $353K.
  • Bogle Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
  • Bogle Investment Management's IVERIC bio, Inc. Common Stock position peaked at $6.18M in Q4 2016.
  • 119 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.